Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Functional heterogeneity of exosomes in hepatocellular carcinoma (Review). Local targets link to admitted publications; unresolved targets remain external evidence.
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
10.3322/caac.21660 · 2021 · External reference
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
10.3322/caac.21660 · 2021 · External reference
Worldwide incidence of hepatocellular carcinoma cases attributable to major risk factors
10.1097/cej.0000000000000428 · 2018 · External reference
Worldwide incidence of hepatocellular carcinoma cases attributable to major risk factors
10.1097/cej.0000000000000428 · 2018 · External reference
Goals and targets for personalized therapy for HCC
10.1007/s12072-018-9919-1 · 2019 · External reference
Goals and targets for personalized therapy for HCC
10.1007/s12072-018-9919-1 · 2019 · External reference
Addressing the worldwide hepatocellular carcinoma: Epidemiology, prevention and management
10.21037/jgo.2020.02.08 · 2021 · External reference
Addressing the worldwide hepatocellular carcinoma: Epidemiology, prevention and management
10.21037/jgo.2020.02.08 · 2021 · External reference
A global view of hepatocellular carcinoma: trends, risk, prevention and management
10.1038/s41575-019-0186-y · 2019 · External reference
A global view of hepatocellular carcinoma: trends, risk, prevention and management
10.1038/s41575-019-0186-y · 2019 · External reference
Hepatitis B Virus DNA integration drives carcinogenesis and provides a new biomarker for HBV-related HCC
10.1016/j.jcmgh.2023.01.001 · 2023 · External reference
Hepatitis B Virus DNA integration drives carcinogenesis and provides a new biomarker for HBV-related HCC
10.1016/j.jcmgh.2023.01.001 · 2023 · External reference
Prognostic MicroRNA Panel for HCV-Associated HCC: Integrating computational biology and clinical validation
10.3390/cancers14133036 · 2022 · External reference
Prognostic MicroRNA Panel for HCV-Associated HCC: Integrating computational biology and clinical validation
10.3390/cancers14133036 · 2022 · External reference
From NASH to HCC: Current concepts and future challenges
10.1038/s41575-019-0145-7 · 2019 · External reference
From NASH to HCC: Current concepts and future challenges
10.1038/s41575-019-0145-7 · 2019 · External reference
Comparison of a multitarget blood test to ultrasound and alpha-fetoprotein for hepatocellular carcinoma surveillance: Results of a network meta-analysis
10.1002/hep4.2045 · 2022 · External reference
Comparison of a multitarget blood test to ultrasound and alpha-fetoprotein for hepatocellular carcinoma surveillance: Results of a network meta-analysis
10.1002/hep4.2045 · 2022 · External reference
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
10.1038/s41586-019-0987-8 · 2019 · External reference
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
10.1038/s41586-019-0987-8 · 2019 · External reference
The trends in death of primary liver cancer caused by specific etiologies worldwide: Results from the Global Burden of Disease Study 2019 and implications for liver cancer management
10.1186/s12885-023-11038-3 · 2023 · External reference
The trends in death of primary liver cancer caused by specific etiologies worldwide: Results from the Global Burden of Disease Study 2019 and implications for liver cancer management
10.1186/s12885-023-11038-3 · 2023 · External reference
New advances in the diagnosis and management of hepatocellular carcinoma
10.1136/bmj.m3544 · 2020 · External reference
New advances in the diagnosis and management of hepatocellular carcinoma
10.1136/bmj.m3544 · 2020 · External reference
The mortality and overall survival trends of primary liver cancer in the United States
10.1093/jnci/djab079 · 2021 · External reference
The mortality and overall survival trends of primary liver cancer in the United States
10.1093/jnci/djab079 · 2021 · External reference
Exosomes: Isolation, characterization, and biomedical applications
10.1002/cbin.11620 · 2021 · External reference
Exosomes: Isolation, characterization, and biomedical applications
10.1002/cbin.11620 · 2021 · External reference
Exosomal miR-4800-3p aggravates the progression of hepatocellular carcinoma via regulating the hippo signaling pathway by targeting STK25
10.3389/fonc.2022.759864 · 2022 · External reference
Exosomal miR-4800-3p aggravates the progression of hepatocellular carcinoma via regulating the hippo signaling pathway by targeting STK25
10.3389/fonc.2022.759864 · 2022 · External reference
Cancer-derived exosomal HSPC111 promotes colorectal cancer liver metastasis by reprogramming lipid metabolism in cancer-associated fibroblasts
10.1038/s41419-022-04506-4 · 2022 · External reference
Cancer-derived exosomal HSPC111 promotes colorectal cancer liver metastasis by reprogramming lipid metabolism in cancer-associated fibroblasts
10.1038/s41419-022-04506-4 · 2022 · External reference
Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma
10.1186/s12943-023-01759-1 · 2023 · External reference
Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma
10.1186/s12943-023-01759-1 · 2023 · External reference
Exosomal miR-125b exerts anti-metastatic properties and predicts early metastasis of hepatocellular carcinoma
10.3389/fonc.2021.637247 · 2021 · External reference
Exosomal miR-125b exerts anti-metastatic properties and predicts early metastasis of hepatocellular carcinoma
10.3389/fonc.2021.637247 · 2021 · External reference
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): A position statement of the International society for extracellular vesicles and update of the MISEV2014 guidelines
10.1080/20013078.2018.1535750 · 2018 · External reference
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): A position statement of the International society for extracellular vesicles and update of the MISEV2014 guidelines
10.1080/20013078.2018.1535750 · 2018 · External reference
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches
10.1002/jev2.12404 · 2024 · External reference
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches
10.1002/jev2.12404 · 2024 · External reference
Dendritic cell extracellular vesicles
10.1016/bs.ircmb.2019.08.005 · 2019 · External reference
Dendritic cell extracellular vesicles
10.1016/bs.ircmb.2019.08.005 · 2019 · External reference
Exosome-derived circTRPS1 promotes malignant phenotype and CD8+ T cell exhaustion in bladder cancer microenvironments
10.1016/j.ymthe.2022.01.022 · 2022 · External reference
Exosome-derived circTRPS1 promotes malignant phenotype and CD8+ T cell exhaustion in bladder cancer microenvironments
10.1016/j.ymthe.2022.01.022 · 2022 · External reference
The emerging role of extracellular vesicles in the testis
10.1093/humrep/dead015 · 2023 · External reference
The emerging role of extracellular vesicles in the testis
10.1093/humrep/dead015 · 2023 · External reference
Saliva diagnostics
10.1146/annurev-anchem-061020-123959 · 2022 · External reference
Saliva diagnostics
10.1146/annurev-anchem-061020-123959 · 2022 · External reference
Urinary extracellular vesicles: A position paper by the Urine Task Force of the International society for extracellular vesicles
10.1002/jev2.12093 · 2021 · External reference
Urinary extracellular vesicles: A position paper by the Urine Task Force of the International society for extracellular vesicles
10.1002/jev2.12093 · 2021 · External reference
The roles of extracellular vesicles in the immune system
10.1038/s41577-022-00763-8 · 2023 · External reference
The roles of extracellular vesicles in the immune system
10.1038/s41577-022-00763-8 · 2023 · External reference
Human bronchial epithelial cell-derived extracellular vesicle therapy for pulmonary fibrosis via inhibition of TGF-β-WNT crosstalk
10.1002/jev2.12124 · 2021 · External reference
Human bronchial epithelial cell-derived extracellular vesicle therapy for pulmonary fibrosis via inhibition of TGF-β-WNT crosstalk
10.1002/jev2.12124 · 2021 · External reference
Extracellular vesicle-loaded hydrogels for tissue repair and regeneration
10.1016/j.mtbio.2022.100522 · 2023 · External reference
Extracellular vesicle-loaded hydrogels for tissue repair and regeneration
10.1016/j.mtbio.2022.100522 · 2023 · External reference
Exosome and virus infection
10.3389/fimmu.2023.1154217 · 2023 · External reference
Exosome and virus infection
10.3389/fimmu.2023.1154217 · 2023 · External reference
Exosome-mediated communication in the tumor microenvironment contributes to hepatocellular carcinoma development and progression
10.1186/s13045-019-0739-0 · 2019 · External reference
Exosome-mediated communication in the tumor microenvironment contributes to hepatocellular carcinoma development and progression
10.1186/s13045-019-0739-0 · 2019 · External reference
Extracellular vesicles as ‘Very Important particles’ (VIPs) in aging
10.3390/ijms24044250 · 2023 · External reference
Extracellular vesicles as ‘Very Important particles’ (VIPs) in aging
10.3390/ijms24044250 · 2023 · External reference
Membrane vesicles, current state-of-the-art: Emerging role of extracellular vesicles
10.1007/s00018-011-0689-3 · 2011 · External reference
Membrane vesicles, current state-of-the-art: Emerging role of extracellular vesicles
10.1007/s00018-011-0689-3 · 2011 · External reference
Exosome processing and characterization approaches for research and technology development
10.1002/advs.202103222 · 2022 · External reference
Exosome processing and characterization approaches for research and technology development
10.1002/advs.202103222 · 2022 · External reference
Lipids in exosomes: Current knowledge and the way forward
10.1016/j.plipres.2017.03.001 · 2017 · External reference
Lipids in exosomes: Current knowledge and the way forward
10.1016/j.plipres.2017.03.001 · 2017 · External reference
Exosomal microRNAs as biomarkers and therapeutic targets for hepatocellular carcinoma
10.3390/ijms22094997 · 2021 · External reference
Exosomal microRNAs as biomarkers and therapeutic targets for hepatocellular carcinoma
10.3390/ijms22094997 · 2021 · External reference
Exosomes-Nature's lipid nanoparticles, a rising star in drug delivery and diagnostics
10.1021/acsnano.2c08774 · 2022 · External reference
Exosomes-Nature's lipid nanoparticles, a rising star in drug delivery and diagnostics
10.1021/acsnano.2c08774 · 2022 · External reference
Find-me and eat-me signals in apoptotic cell clearance: Progress and conundrums
10.1084/jem.20101157 · 2010 · External reference
Find-me and eat-me signals in apoptotic cell clearance: Progress and conundrums
10.1084/jem.20101157 · 2010 · External reference
An apoptotic ‘eat me’ signal: Phosphatidylserine exposure
10.1016/j.tcb.2015.08.003 · 2015 · External reference
An apoptotic ‘eat me’ signal: Phosphatidylserine exposure
10.1016/j.tcb.2015.08.003 · 2015 · External reference
The biology, function, and applications of exosomes in cancer
10.1016/j.apsb.2021.01.001 · 2021 · External reference
The biology, function, and applications of exosomes in cancer
10.1016/j.apsb.2021.01.001 · 2021 · External reference
Bro1 stimulates Vps4 to promote intralumenal vesicle formation during multivesicular body biogenesis
10.1083/jcb.202102070 · 2021 · External reference
Bro1 stimulates Vps4 to promote intralumenal vesicle formation during multivesicular body biogenesis
10.1083/jcb.202102070 · 2021 · External reference
RAB31 marks and controls an ESCRT-independent exosome pathway
10.1038/s41422-020-00409-1 · 2021 · External reference
RAB31 marks and controls an ESCRT-independent exosome pathway
10.1038/s41422-020-00409-1 · 2021 · External reference
Methods for the identification and characterization of extracellular vesicles in cardiovascular studies: From exosomes to microvesicles
10.1093/cvr/cvac031 · 2023 · External reference
Methods for the identification and characterization of extracellular vesicles in cardiovascular studies: From exosomes to microvesicles
10.1093/cvr/cvac031 · 2023 · External reference
Microfluidic approaches for affinity-based exosome separation
10.3390/ijms23169004 · 2022 · External reference
Microfluidic approaches for affinity-based exosome separation
10.3390/ijms23169004 · 2022 · External reference
Isolation of extracellular vesicles: General methodologies and latest trends
10.1155/2018/8545347 · 2018 · External reference
Isolation of extracellular vesicles: General methodologies and latest trends
10.1155/2018/8545347 · 2018 · External reference
Current status and outlook of advances in exosome isolation
10.1007/s00216-022-04253-7 · 2022 · External reference
Current status and outlook of advances in exosome isolation
10.1007/s00216-022-04253-7 · 2022 · External reference
Exosomes: Large-scale production, isolation, drug loading efficiency, and biodistribution and uptake
10.1016/j.jconrel.2022.05.027 · 2022 · External reference
Exosomes: Large-scale production, isolation, drug loading efficiency, and biodistribution and uptake
10.1016/j.jconrel.2022.05.027 · 2022 · External reference
Separation of distinct exosome subpopulations: isolation and characterization approaches and their associated challenges
10.1039/d1an00024a · 2021 · External reference
Separation of distinct exosome subpopulations: isolation and characterization approaches and their associated challenges
10.1039/d1an00024a · 2021 · External reference
Exosomes as a new frontier of cancer liquid biopsy
10.1186/s12943-022-01509-9 · 2022 · External reference
Exosomes as a new frontier of cancer liquid biopsy
10.1186/s12943-022-01509-9 · 2022 · External reference
Mesenchymal stem cell-derived exosomes: Applications in regenerative medicine
10.3390/cells10081959 · 2021 · External reference
Mesenchymal stem cell-derived exosomes: Applications in regenerative medicine
10.3390/cells10081959 · 2021 · External reference
A review on comparative studies addressing exosome isolation methods from body fluids
10.1007/s00216-022-04174-5 · 2023 · External reference
A review on comparative studies addressing exosome isolation methods from body fluids
10.1007/s00216-022-04174-5 · 2023 · External reference
The Yin and Yang of exosome isolation methods: Conventional practice, microfluidics, and commercial kits
10.1016/j.biotechadv.2021.107814 · 2022 · External reference
The Yin and Yang of exosome isolation methods: Conventional practice, microfluidics, and commercial kits
10.1016/j.biotechadv.2021.107814 · 2022 · External reference
Recent progress in exosome research: Isolation, characterization and clinical applications
10.1038/s41417-023-00617-y · 2023 · External reference
Recent progress in exosome research: Isolation, characterization and clinical applications
10.1038/s41417-023-00617-y · 2023 · External reference
Exosomes: The latest in regenerative aesthetics
10.2217/rme-2022-0134 · 2023 · External reference
Exosomes: The latest in regenerative aesthetics
10.2217/rme-2022-0134 · 2023 · External reference
Exosomes in chronic respiratory diseases
10.1016/j.biopha.2021.112270 · 2021 · External reference
Exosomes in chronic respiratory diseases
10.1016/j.biopha.2021.112270 · 2021 · External reference
Exosome-based smart drug delivery tool for cancer theranostics
10.1021/acsbiomaterials.2c01329 · 2023 · External reference
Exosome-based smart drug delivery tool for cancer theranostics
10.1021/acsbiomaterials.2c01329 · 2023 · External reference
Emerging technologies and commercial products in exosome-based cancer diagnosis and prognosis
10.1016/j.bios.2021.113176 · 2021 · External reference
Emerging technologies and commercial products in exosome-based cancer diagnosis and prognosis
10.1016/j.bios.2021.113176 · 2021 · External reference
The exosome: A review of current therapeutic roles and capabilities in human reproduction
10.1007/s13346-022-01225-3 · 2023 · External reference
The exosome: A review of current therapeutic roles and capabilities in human reproduction
10.1007/s13346-022-01225-3 · 2023 · External reference
Biogenesis, isolation, and detection of exosomes and their potential in therapeutics and diagnostics
10.3390/bios13080802 · 2023 · External reference
Biogenesis, isolation, and detection of exosomes and their potential in therapeutics and diagnostics
10.3390/bios13080802 · 2023 · External reference
Exosomes as powerful engines in cancer: Isolation, characterization and detection techniques
10.3390/bios11120518 · 2021 · External reference
Exosomes as powerful engines in cancer: Isolation, characterization and detection techniques
10.3390/bios11120518 · 2021 · External reference
Comparison of the extraction methods of plasma exosomes from human umbilical cord blood
10.13345/j.cjb.210919 · 2022 · External reference
Comparison of the extraction methods of plasma exosomes from human umbilical cord blood
10.13345/j.cjb.210919 · 2022 · External reference
Methodological guidelines to study extracellular vesicles
10.1161/circresaha.117.309417 · 2017 · External reference
Methodological guidelines to study extracellular vesicles
10.1161/circresaha.117.309417 · 2017 · External reference
Considerations towards a roadmap for collection, handling and storage of blood extracellular vesicles
10.1080/20013078.2019.1647027 · 2019 · External reference
Considerations towards a roadmap for collection, handling and storage of blood extracellular vesicles
10.1080/20013078.2019.1647027 · 2019 · External reference
Hepatocyte exosomes mediate liver repair and regeneration via sphingosine-1-phosphate
10.1016/j.jhep.2015.07.030 · 2016 · External reference
Hepatocyte exosomes mediate liver repair and regeneration via sphingosine-1-phosphate
10.1016/j.jhep.2015.07.030 · 2016 · External reference
Unraveling the emerging niche role of hepatic stellate cell-derived exosomes in liver diseases
10.14218/jcth.2022.00326 · 2023 · External reference
Unraveling the emerging niche role of hepatic stellate cell-derived exosomes in liver diseases
10.14218/jcth.2022.00326 · 2023 · External reference
Salidroside Inhibits CCl(4)-induced liver fibrosis in mice by reducing activation and migration of HSC induced by liver sinusoidal endothelial cell-derived exosomal SphK1
10.3389/fphar.2021.677810 · 2021 · External reference
Salidroside Inhibits CCl(4)-induced liver fibrosis in mice by reducing activation and migration of HSC induced by liver sinusoidal endothelial cell-derived exosomal SphK1
10.3389/fphar.2021.677810 · 2021 · External reference
Cholangiocyte-derived exosomal lncRNA H19 promotes macrophage activation and hepatic inflammation under cholestatic conditions
10.3390/cells9010190 · 2020 · External reference
Cholangiocyte-derived exosomal lncRNA H19 promotes macrophage activation and hepatic inflammation under cholestatic conditions
10.3390/cells9010190 · 2020 · External reference
Liver-derived exosomes and their implications in liver pathobiology
10.3390/ijms19123715 · 2018 · External reference
Liver-derived exosomes and their implications in liver pathobiology
10.3390/ijms19123715 · 2018 · External reference
MiR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells improve hepatocellular carcinoma chemosensitivity through mTOR pathway
10.1186/s13046-019-1512-5 · 2020 · External reference
MiR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells improve hepatocellular carcinoma chemosensitivity through mTOR pathway
10.1186/s13046-019-1512-5 · 2020 · External reference
Emerging concepts of miRNA therapeutics: From cells to clinic
10.1016/j.tig.2022.02.006 · 2022 · External reference
Emerging concepts of miRNA therapeutics: From cells to clinic
10.1016/j.tig.2022.02.006 · 2022 · External reference
Exosome-depleted MiR-148a-3p derived from hepatic stellate cells promotes tumor progression via ITGA5/PI3K/Akt axis in hepatocellular carcinoma
10.7150/ijbs.66184 · 2022 · External reference
Exosome-depleted MiR-148a-3p derived from hepatic stellate cells promotes tumor progression via ITGA5/PI3K/Akt axis in hepatocellular carcinoma
10.7150/ijbs.66184 · 2022 · External reference
The significance of exosomes in the development and treatment of hepatocellular carcinoma
10.1186/s12943-019-1085-0 · 2020 · External reference
The significance of exosomes in the development and treatment of hepatocellular carcinoma
10.1186/s12943-019-1085-0 · 2020 · External reference
Exosome-based liquid biopsies in cancer: Opportunities and challenges
10.1016/j.annonc.2021.01.074 · 2021 · External reference
Exosome-based liquid biopsies in cancer: Opportunities and challenges
10.1016/j.annonc.2021.01.074 · 2021 · External reference
Serum exosomal MicroRNA, miR-10b-5p, as a potential diagnostic biomarker for early-stage hepatocellular carcinoma
10.3390/jcm9010281 · 2020 · External reference
Serum exosomal MicroRNA, miR-10b-5p, as a potential diagnostic biomarker for early-stage hepatocellular carcinoma
10.3390/jcm9010281 · 2020 · External reference
Serum-Exosome-Derived miRNAs serve as promising biomarkers for HCC diagnosis
10.3390/cancers15010205 · 2022 · External reference
Serum-Exosome-Derived miRNAs serve as promising biomarkers for HCC diagnosis
10.3390/cancers15010205 · 2022 · External reference
Global burden of primary liver cancer in 2020 and predictions to 2040
10.1016/j.jhep.2022.08.021 · 2022 · External reference
Global burden of primary liver cancer in 2020 and predictions to 2040
10.1016/j.jhep.2022.08.021 · 2022 · External reference
Exosomal miR-374c-5p derived from mesenchymal stem cells suppresses epithelial-mesenchymal transition of hepatocellular carcinoma via the LIMK1-Wnt/β-catenin axis
10.1002/tox.23746 · 2023 · External reference
Exosomal miR-374c-5p derived from mesenchymal stem cells suppresses epithelial-mesenchymal transition of hepatocellular carcinoma via the LIMK1-Wnt/β-catenin axis
10.1002/tox.23746 · 2023 · External reference
Exosomal miR-3682-3p suppresses angiogenesis by targeting ANGPT1 via the RAS-MEK1/2-ERK1/2 pathway in hepatocellular carcinoma
10.3389/fcell.2021.633358 · 2021 · External reference
Exosomal miR-3682-3p suppresses angiogenesis by targeting ANGPT1 via the RAS-MEK1/2-ERK1/2 pathway in hepatocellular carcinoma
10.3389/fcell.2021.633358 · 2021 · External reference
Hepatocellular carcinoma cell-derived exosomal miR-21-5p promotes the polarization of tumor-related macrophages (TAMs) through SP1/XBP1 and affects the progression of hepatocellular carcinoma
10.1016/j.intimp.2023.111149 · 2024 · External reference
Hepatocellular carcinoma cell-derived exosomal miR-21-5p promotes the polarization of tumor-related macrophages (TAMs) through SP1/XBP1 and affects the progression of hepatocellular carcinoma
10.1016/j.intimp.2023.111149 · 2024 · External reference
Overexpression of miR-4669 enhances tumor aggressiveness and generates an immunosuppressive tumor microenvironment in hepatocellular carcinoma: Its clinical value as a predictive biomarker
10.3390/ijms24097908 · 2023 · External reference
Overexpression of miR-4669 enhances tumor aggressiveness and generates an immunosuppressive tumor microenvironment in hepatocellular carcinoma: Its clinical value as a predictive biomarker
10.3390/ijms24097908 · 2023 · External reference
CAF-Released exosomal miR-20a-5p facilitates HCC progression via the LIMA1-Mediated β-catenin pathway
10.3390/cells11233857 · 2022 · External reference
CAF-Released exosomal miR-20a-5p facilitates HCC progression via the LIMA1-Mediated β-catenin pathway
10.3390/cells11233857 · 2022 · External reference
Exosomal miR-628-5p from M1 polarized macrophages hinders m6A modification of circFUT8 to suppress hepatocellular carcinoma progression
10.1186/s11658-022-00406-9 · 2022 · External reference
Exosomal miR-628-5p from M1 polarized macrophages hinders m6A modification of circFUT8 to suppress hepatocellular carcinoma progression
10.1186/s11658-022-00406-9 · 2022 · External reference
Exosomal MiR-1290 promotes angiogenesis of hepatocellular carcinoma via targeting SMEK1
10.1155/2021/6617700 · 2021 · External reference
Exosomal MiR-1290 promotes angiogenesis of hepatocellular carcinoma via targeting SMEK1
10.1155/2021/6617700 · 2021 · External reference
Exosomal miR-200b-3p induce macrophage polarization by regulating transcriptional repressor ZEB1 in hepatocellular carcinoma
10.1007/s12072-023-10507-y · 2023 · External reference
Exosomal miR-200b-3p induce macrophage polarization by regulating transcriptional repressor ZEB1 in hepatocellular carcinoma
10.1007/s12072-023-10507-y · 2023 · External reference
Cancer-associated fibroblasts promote hepatocellular carcinoma progression through downregulation of exosomal miR-150-3p
10.1016/j.ejso.2020.08.002 · 2021 · External reference
Cancer-associated fibroblasts promote hepatocellular carcinoma progression through downregulation of exosomal miR-150-3p
10.1016/j.ejso.2020.08.002 · 2021 · External reference
Exosomal miR-452-5p induce M2 macrophage polarization to accelerate hepatocellular carcinoma progression by targeting TIMP3
10.1155/2022/1032106 · 2022 · External reference
Exosomal miR-452-5p induce M2 macrophage polarization to accelerate hepatocellular carcinoma progression by targeting TIMP3
10.1155/2022/1032106 · 2022 · External reference
Bone lesion-derived extracellular vesicles fuel prometastatic cascades in hepatocellular carcinoma by transferring ALKBH5-Targeting miR-3190-5p
10.1002/advs.202207080 · 2023 · External reference
Bone lesion-derived extracellular vesicles fuel prometastatic cascades in hepatocellular carcinoma by transferring ALKBH5-Targeting miR-3190-5p
10.1002/advs.202207080 · 2023 · External reference
High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN/Akt pathway in hepatocellular carcinoma
10.1038/s41388-020-01450-5 · 2020 · External reference
High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN/Akt pathway in hepatocellular carcinoma
10.1038/s41388-020-01450-5 · 2020 · External reference
Higher matrix stiffness as an independent initiator triggers epithelial-mesenchymal transition and facilitates HCC metastasis
10.1186/s13045-019-0795-5 · 2019 · External reference
Higher matrix stiffness as an independent initiator triggers epithelial-mesenchymal transition and facilitates HCC metastasis
10.1186/s13045-019-0795-5 · 2019 · External reference
Clinical implication of circulating tumor cells expressing epithelial mesenchymal transition (EMT) and cancer stem cell (CSC) markers and their perspective in HCC: A systematic review
10.3390/cancers14143373 · 2022 · External reference
Clinical implication of circulating tumor cells expressing epithelial mesenchymal transition (EMT) and cancer stem cell (CSC) markers and their perspective in HCC: A systematic review
10.3390/cancers14143373 · 2022 · External reference
Molecular mechanisms of epithelial-mesenchymal transition
10.1038/nrm3758 · 2014 · External reference
Molecular mechanisms of epithelial-mesenchymal transition
10.1038/nrm3758 · 2014 · External reference
The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis
10.1186/s13045-022-01347-8 · 2022 · External reference
The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis
10.1186/s13045-022-01347-8 · 2022 · External reference
MiR-4521 plays a tumor repressive role in growth and metastasis of hepatocarcinoma cells by suppressing phosphorylation of FAK/AKT pathway via targeting FAM129A
10.1016/j.jare.2021.05.003 · 2021 · External reference
MiR-4521 plays a tumor repressive role in growth and metastasis of hepatocarcinoma cells by suppressing phosphorylation of FAK/AKT pathway via targeting FAM129A
10.1016/j.jare.2021.05.003 · 2021 · External reference
Serum exosomal miR-638 is a prognostic marker of HCC via downregulation of VE-cadherin and ZO-1 of endothelial cells
10.1111/cas.14807 · 2021 · External reference
Serum exosomal miR-638 is a prognostic marker of HCC via downregulation of VE-cadherin and ZO-1 of endothelial cells
10.1111/cas.14807 · 2021 · External reference
Jianpi Huayu decoction inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells by suppressing exosomal miR-23a-3p/Smad signaling
10.1016/j.jep.2022.115360 · 2022 · External reference
Jianpi Huayu decoction inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells by suppressing exosomal miR-23a-3p/Smad signaling
10.1016/j.jep.2022.115360 · 2022 · External reference
The Crosstalk between Tumor Cells and the Microenvironment in Hepatocellular Carcinoma: The Role of Exosomal microRNAs and their Clinical Implications
10.3390/cancers12040823 · 2020 · External reference
The Crosstalk between Tumor Cells and the Microenvironment in Hepatocellular Carcinoma: The Role of Exosomal microRNAs and their Clinical Implications
10.3390/cancers12040823 · 2020 · External reference
A novel polypeptide encoded by the circular RNA ZKSCAN1 suppresses HCC via degradation of mTOR
10.1186/s12943-023-01719-9 · 2023 · External reference
A novel polypeptide encoded by the circular RNA ZKSCAN1 suppresses HCC via degradation of mTOR
10.1186/s12943-023-01719-9 · 2023 · External reference
Circular RNAs: Characterization, cellular roles, and applications
10.1016/j.cell.2022.04.021 · 2022 · External reference
Circular RNAs: Characterization, cellular roles, and applications
10.1016/j.cell.2022.04.021 · 2022 · External reference
CircARID1A binds to IGF2BP3 in gastric cancer and promotes cancer proliferation by forming a circARID1A-IGF2BP3-SLC7A5 RNA-protein ternary complex
10.1186/s13046-022-02466-3 · 2022 · External reference
CircARID1A binds to IGF2BP3 in gastric cancer and promotes cancer proliferation by forming a circARID1A-IGF2BP3-SLC7A5 RNA-protein ternary complex
10.1186/s13046-022-02466-3 · 2022 · External reference
Exosomal circGSE1 promotes immune escape of hepatocellular carcinoma by inducing the expansion of regulatory T cells
10.1111/cas.15365 · 2022 · External reference
Exosomal circGSE1 promotes immune escape of hepatocellular carcinoma by inducing the expansion of regulatory T cells
10.1111/cas.15365 · 2022 · External reference
Identification of lncRNA/circRNA-miRNA-mRNA ceRNA network as biomarkers for hepatocellular carcinoma
10.3389/fgene.2022.838869 · 2022 · External reference
Identification of lncRNA/circRNA-miRNA-mRNA ceRNA network as biomarkers for hepatocellular carcinoma
10.3389/fgene.2022.838869 · 2022 · External reference
Comprehensive analysis of the competing endogenous circRNA-lncRNA-miRNA-mRNA network and identification of a novel potential biomarker for hepatocellular carcinoma
10.18632/aging.203056 · 2021 · External reference
Comprehensive analysis of the competing endogenous circRNA-lncRNA-miRNA-mRNA network and identification of a novel potential biomarker for hepatocellular carcinoma
10.18632/aging.203056 · 2021 · External reference
Exosomal hsa_circ_0004658 derived from RBPJ overexpressed-macrophages inhibits hepatocellular carcinoma progression via miR-499b-5p/JAM3
10.1038/s41419-021-04345-9 · 2022 · External reference
Exosomal hsa_circ_0004658 derived from RBPJ overexpressed-macrophages inhibits hepatocellular carcinoma progression via miR-499b-5p/JAM3
10.1038/s41419-021-04345-9 · 2022 · External reference
Exosomal circTGFBR2 promotes hepatocellular carcinoma progression via enhancing ATG5 mediated protective autophagy
10.1038/s41419-023-05989-5 · 2023 · External reference
Exosomal circTGFBR2 promotes hepatocellular carcinoma progression via enhancing ATG5 mediated protective autophagy
10.1038/s41419-023-05989-5 · 2023 · External reference
Tumor cell-derived exosomal Circ-0072088 suppresses migration and invasion of hepatic carcinoma cells through regulating MMP-16
10.3389/fcell.2021.726323 · 2021 · External reference
Tumor cell-derived exosomal Circ-0072088 suppresses migration and invasion of hepatic carcinoma cells through regulating MMP-16
10.3389/fcell.2021.726323 · 2021 · External reference
Exosome-transmitted circ_MMP2 promotes hepatocellular carcinoma metastasis by upregulating MMP2
10.1002/1878-0261.12637 · 2020 · External reference
Exosome-transmitted circ_MMP2 promotes hepatocellular carcinoma metastasis by upregulating MMP2
10.1002/1878-0261.12637 · 2020 · External reference
Circular RNA hsa_circ_0004277 stimulates malignant phenotype of hepatocellular carcinoma and epithelial-mesenchymal transition of peripheral cells
10.3389/fcell.2020.585565 · 2021 · External reference
Circular RNA hsa_circ_0004277 stimulates malignant phenotype of hepatocellular carcinoma and epithelial-mesenchymal transition of peripheral cells
10.3389/fcell.2020.585565 · 2021 · External reference
Immunotherapies for hepatocellular carcinoma
10.1038/s41571-021-00573-2 · 2022 · External reference
Immunotherapies for hepatocellular carcinoma
10.1038/s41571-021-00573-2 · 2022 · External reference
Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma
10.3389/fimmu.2023.1133308 · 2023 · External reference
Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma
10.3389/fimmu.2023.1133308 · 2023 · External reference
Tumor-associated macrophages in liver cancer: From mechanisms to therapy
10.1002/cac2.12345 · 2022 · External reference
Tumor-associated macrophages in liver cancer: From mechanisms to therapy
10.1002/cac2.12345 · 2022 · External reference
Bispecific antibody CD73xEpCAM selectively inhibits the adenosine-mediated immunosuppressive activity of carcinoma-derived extracellular vesicles
10.1016/j.canlet.2021.08.037 · 2021 · External reference
Bispecific antibody CD73xEpCAM selectively inhibits the adenosine-mediated immunosuppressive activity of carcinoma-derived extracellular vesicles
10.1016/j.canlet.2021.08.037 · 2021 · External reference
Amplification of spatially isolated adenosine pathway by tumor-macrophage interaction induces anti-PD1 resistance in hepatocellular carcinoma
10.1186/s13045-021-01207-x · 2021 · External reference
Amplification of spatially isolated adenosine pathway by tumor-macrophage interaction induces anti-PD1 resistance in hepatocellular carcinoma
10.1186/s13045-021-01207-x · 2021 · External reference
CircPAK1 promotes the progression of hepatocellular carcinoma via modulation of YAP nucleus localization by interacting with 14-3-3ζ
10.1186/s13046-022-02494-z · 2022 · External reference
CircPAK1 promotes the progression of hepatocellular carcinoma via modulation of YAP nucleus localization by interacting with 14-3-3ζ
10.1186/s13046-022-02494-z · 2022 · External reference
An emerging research: the role of hepatocellular carcinoma-derived exosomal circRNAs in the immune microenvironment
10.3389/fimmu.2023.1227150 · 2023 · External reference
An emerging research: the role of hepatocellular carcinoma-derived exosomal circRNAs in the immune microenvironment
10.3389/fimmu.2023.1227150 · 2023 · External reference
Integrated lncRNA function upon genomic and epigenomic regulation
10.1016/j.molcel.2022.05.027 · 2022 · External reference
Integrated lncRNA function upon genomic and epigenomic regulation
10.1016/j.molcel.2022.05.027 · 2022 · External reference
LNCcation: lncRNA localization and function
10.1083/jcb.202009045 · 2021 · External reference
LNCcation: lncRNA localization and function
10.1083/jcb.202009045 · 2021 · External reference
Tumor immune microenvironment lncRNAs
10.1093/bib/bbab504 · 2022 · External reference
Tumor immune microenvironment lncRNAs
10.1093/bib/bbab504 · 2022 · External reference
lncRNAfunc: A knowledgebase of lncRNA function in human cancer
10.1093/nar/gkab1035 · 2022 · External reference
lncRNAfunc: A knowledgebase of lncRNA function in human cancer
10.1093/nar/gkab1035 · 2022 · External reference
Tumor associated macrophages-derived exosomes facilitate hepatocellular carcinoma malignance by transferring lncMMPA to tumor cells and activating glycolysis pathway
10.1186/s13046-022-02458-3 · 2022 · External reference
Tumor associated macrophages-derived exosomes facilitate hepatocellular carcinoma malignance by transferring lncMMPA to tumor cells and activating glycolysis pathway
10.1186/s13046-022-02458-3 · 2022 · External reference
Exosomal ZFPM2-AS1 contributes to tumorigenesis, metastasis, stemness, macrophage polarization, and infiltration in hepatocellular carcinoma through PKM mediated glycolysis
10.1002/tox.23767 · 2023 · External reference
Exosomal ZFPM2-AS1 contributes to tumorigenesis, metastasis, stemness, macrophage polarization, and infiltration in hepatocellular carcinoma through PKM mediated glycolysis
10.1002/tox.23767 · 2023 · External reference
Exosomal lncRNA TUG1 from cancer-associated fibroblasts promotes liver cancer cell migration, invasion, and glycolysis by regulating the miR-524-5p/SIX1 axis
10.1186/s11658-022-00309-9 · 2022 · External reference
Exosomal lncRNA TUG1 from cancer-associated fibroblasts promotes liver cancer cell migration, invasion, and glycolysis by regulating the miR-524-5p/SIX1 axis
10.1186/s11658-022-00309-9 · 2022 · External reference
Exosomal LINC00161 promotes angiogenesis and metastasis via regulating miR-590-3p/ROCK axis in hepatocellular carcinoma
10.1038/s41417-020-00269-2 · 2021 · External reference
Exosomal LINC00161 promotes angiogenesis and metastasis via regulating miR-590-3p/ROCK axis in hepatocellular carcinoma
10.1038/s41417-020-00269-2 · 2021 · External reference
Advances and challenges of exosome-derived noncoding RNAs for hepatocellular carcinoma diagnosis and treatment
10.1016/j.bbrep.2024.101695 · 2024 · External reference
Advances and challenges of exosome-derived noncoding RNAs for hepatocellular carcinoma diagnosis and treatment
10.1016/j.bbrep.2024.101695 · 2024 · External reference
The updated role of exosomal proteins in the diagnosis, prognosis, and treatment of cancer
10.1038/s12276-022-00855-4 · 2022 · External reference
The updated role of exosomal proteins in the diagnosis, prognosis, and treatment of cancer
10.1038/s12276-022-00855-4 · 2022 · External reference
10.1021/acsomega.0c05408 · 2021 · Admitted local publication
10.1021/acsomega.0c05408 · 2021 · Admitted local publication
Overexpressed proteins in HCC cell-derived exosomes, CCT8, and cofilin-1 are potential biomarkers for patients with HCC
10.3390/diagnostics11071221 · 2021 · External reference
Overexpressed proteins in HCC cell-derived exosomes, CCT8, and cofilin-1 are potential biomarkers for patients with HCC
10.3390/diagnostics11071221 · 2021 · External reference
MIRLET7BHG promotes hepatocellular carcinoma progression by activating hepatic stellate cells through exosomal SMO to trigger Hedgehog pathway
10.1038/s41419-021-03494-1 · 2021 · External reference
MIRLET7BHG promotes hepatocellular carcinoma progression by activating hepatic stellate cells through exosomal SMO to trigger Hedgehog pathway
10.1038/s41419-021-03494-1 · 2021 · External reference
Exosome-derived GTF2H2 from Huh7 cells can inhibit endothelial cell viability, migration, tube formation, and permeability
10.1016/j.tice.2022.101922 · 2022 · External reference
Exosome-derived GTF2H2 from Huh7 cells can inhibit endothelial cell viability, migration, tube formation, and permeability
10.1016/j.tice.2022.101922 · 2022 · External reference
Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1(+) regulatory B cell expansion
10.1186/s40425-018-0451-6 · 2018 · External reference
Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1(+) regulatory B cell expansion
10.1186/s40425-018-0451-6 · 2018 · External reference
Exosomal S100A4 derived from highly metastatic hepatocellular carcinoma cells promotes metastasis by activating STAT3
10.1038/s41392-021-00579-3 · 2021 · External reference
Exosomal S100A4 derived from highly metastatic hepatocellular carcinoma cells promotes metastasis by activating STAT3
10.1038/s41392-021-00579-3 · 2021 · External reference
Exosomal carboxypeptidase E (CPE) and CPE-shRNA-Loaded exosomes regulate metastatic phenotype of tumor cells
10.3390/ijms23063113 · 2022 · External reference
Exosomal carboxypeptidase E (CPE) and CPE-shRNA-Loaded exosomes regulate metastatic phenotype of tumor cells
10.3390/ijms23063113 · 2022 · External reference
Exosomal PD-L1 in hepatocellular carcinoma: Immune evasion mechanisms, diagnostic value, and strategies for therapeutic targeting
10.1016/j.biopha.2026.119268 · 2026 · External reference
Exosomal PD-L1 in hepatocellular carcinoma: Immune evasion mechanisms, diagnostic value, and strategies for therapeutic targeting
10.1016/j.biopha.2026.119268 · 2026 · External reference
Role of extracellular vesicle-associated proteins in the progression, diagnosis, and treatment of hepatocellular carcinoma
10.1186/s13578-024-01294-6 · 2024 · External reference
Role of extracellular vesicle-associated proteins in the progression, diagnosis, and treatment of hepatocellular carcinoma
10.1186/s13578-024-01294-6 · 2024 · External reference
Developing blood extracellular vesicle protein biomarkers for hepatocellular carcinoma: mechanisms, methods, and translation
10.1186/s12951-026-04463-6 · 2026 · External reference
Developing blood extracellular vesicle protein biomarkers for hepatocellular carcinoma: mechanisms, methods, and translation
10.1186/s12951-026-04463-6 · 2026 · External reference
Exosomal microRNA-4661-5p-based serum panel as a potential diagnostic biomarker for early-stage hepatocellular carcinoma
10.1002/cam4.3230 · 2020 · External reference
Exosomal microRNA-4661-5p-based serum panel as a potential diagnostic biomarker for early-stage hepatocellular carcinoma
10.1002/cam4.3230 · 2020 · External reference
The potential of serum exosomal hsa_circ_0028861 as the novel diagnostic biomarker of HBV-derived hepatocellular cancer
10.3389/fgene.2021.703205 · 2021 · External reference
The potential of serum exosomal hsa_circ_0028861 as the novel diagnostic biomarker of HBV-derived hepatocellular cancer
10.3389/fgene.2021.703205 · 2021 · External reference
Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation
10.1038/s41556-018-0040-4 · 2018 · External reference
Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation
10.1038/s41556-018-0040-4 · 2018 · External reference
Asymmetric-flow field-flow fractionation technology for exomere and small extracellular vesicle separation and characterization
10.1038/s41596-019-0126-x · 2019 · External reference
Asymmetric-flow field-flow fractionation technology for exomere and small extracellular vesicle separation and characterization
10.1038/s41596-019-0126-x · 2019 · External reference
Extracellular vesicles in liver disease and potential as biomarkers and therapeutic targets
10.1038/nrgastro.2017.71 · 2017 · External reference
Extracellular vesicles in liver disease and potential as biomarkers and therapeutic targets
10.1038/nrgastro.2017.71 · 2017 · External reference
Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma
10.1186/s12943-020-01222-5 · 2020 · External reference
Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma
10.1186/s12943-020-01222-5 · 2020 · External reference
Exosome-derived SNHG16 sponging miR-4500 activates HUVEC angiogenesis by targeting GALNT1 via PI3K/Akt/mTOR pathway in hepatocellular carcinoma
10.1007/s13105-021-00833-w · 2021 · External reference
Exosome-derived SNHG16 sponging miR-4500 activates HUVEC angiogenesis by targeting GALNT1 via PI3K/Akt/mTOR pathway in hepatocellular carcinoma
10.1007/s13105-021-00833-w · 2021 · External reference
LncRNA MAPKAPK5_AS1 facilitates cell proliferation in hepatitis B virus -related hepatocellular carcinoma
10.1038/s41374-022-00731-9 · 2022 · External reference
LncRNA MAPKAPK5_AS1 facilitates cell proliferation in hepatitis B virus -related hepatocellular carcinoma
10.1038/s41374-022-00731-9 · 2022 · External reference
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer
10.1038/s41467-017-02583-0 · 2018 · External reference
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer
10.1038/s41467-017-02583-0 · 2018 · External reference
EV-TRACK: Transparent reporting and centralizing knowledge in extracellular vesicle research
10.1038/nmeth.4185 · 2017 · External reference
EV-TRACK: Transparent reporting and centralizing knowledge in extracellular vesicle research
10.1038/nmeth.4185 · 2017 · External reference
Extracellular vesicle analysis
10.1038/s43586-023-00240-z · 2023 · External reference
Extracellular vesicle analysis
10.1038/s43586-023-00240-z · 2023 · External reference
